US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Yesterday's Top Gainers

800.73

+15.862.02%

Number of Gainers:38

Number of Losers:15

Number of Flat:4

PE:- -

High:807.74

Open:784.84

Low:784.83

Close:784.87

Loading ...

Top Premarket Decliners

MT Newswires Live

Heron Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Updates

February 2025 Penny Stocks To Keep An Eye On

Simply Wall St.

So-Young to transfer listing to Nasdaq Capital

so-Young Receives Approval to Transfer to Nasdaq Capital Market and Extension of Minimum Bid Price Compliance Period

THOMSON REUTERS

So-Young Receives Approval to Transfer to Nasdaq Capital Market and Extension of Minimum Bid Price Compliance Period

KANZHUN LIMITED to Report Fourth Quarter and FY2024 Results on March 11, 2025

Future of airport operations to take centre stage at inter airport Southeast Asia conference

Goldman Sachs Appoints McClure and Waldron to Board

Vista Energy Announces Shareholders’ Meeting with Key Financial Agenda

BRIEF-Relay Therapeutics Q4 Net Income USD -76.004 Million

Relay Therapeutics Q4 Basic EPS USD -0.45

THOMSON REUTERS

Relay Therapeutics Q4 Operating Expenses USD 84.979 Million

THOMSON REUTERS

Relay Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates

REGENXBIO to Host Conference Call on March 13 to Discuss Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights

Revolution Medicines Reports Fourth Quarter and Full Year 2024 Financial Results and Update on Corporate Progress

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4563/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4563"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4563\",,,,,undefined,":{"symbol":"BK4563","market":"US","secType":"PLATE","nameCN":"Yesterday's Top Gainers","latestPrice":800.73083,"timestamp":1741381199999,"preClose":784.8674,"halted":0,"volume":78879564,"delay":0,"changeRate":0.020212,"change":15.863464,"pbRate":2.353792,"amount":1259822832.909808,"amplitude":0.029191,"prevYearClose":733.5465,"fiveDayClose":790.6026,"twentyDayClose":741.9348,"turnoverRate":0.014254,"marketCap":144472546493,"floatMarketCap":82596524549,"peRate":44.18053},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4563\",,,,,undefined,":{"symbol":"BK4563","high":807.73816,"amplitude":0.029191,"preClose":784.8674,"low":784.8268,"pbRate":"2.353792","latestPrice":800.73083,"volume":78879564,"delay":0,"open":784.83984,"prevYearClose":733.5465,"prevWeekClose":790.6026,"prevMonthClose":790.6026,"prevQuarterClose":733.5465,"fiveDayClose":790.6026,"twentyDayClose":741.9348,"sixtyDayClose":737.8639,"secType":"PLATE","market":"US","turnoverRate":0.014254,"peRate":44.18053,"marketCap":144472546493,"floatMarketCap":82596524549,"timestamp":1741381199999,"nameCN":"Yesterday's Top Gainers"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4563\",,,,undefined,":{"bkCode":"BK4563","up":38,"down":15,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4563\",pageSize:16,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514311801","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2514311801","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514311801?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:50","pubTimestamp":1740660613,"startTime":"0","endTime":"0","summary":"Ibotta  shares slumped 41% pre-bell Thursday after the company reported lower Q4 adjusted profit and revenue late Wednesday.Siyata Mobile  shares fell 27%, reversing from Wednesday's rally.Digimarc  shares retreated 26%, a day after the company reported lower Q4 revenue.TransAlta Corp.  shares dropped 25% after Wednesday's 1.1% gain.Mayville Engineering  shares were down 24% following a muted session.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEC.AU","BK7062","IBTA","BK4023","BK4105","SYTA","BK4020","DMRC","BK4009","BK4563","MEC","TAC","BK4161"],"gpt_icon":0},{"id":"2514804598","title":"Heron Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2514804598","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514804598?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:45","pubTimestamp":1740660300,"startTime":"0","endTime":"0","summary":"Generated full-year 2024 Net Revenue of $144.2 million, up 14% year-over-year. Delivered full-year 2024 adjusted EBITDA of $8.6 million. Generated ZYNRELEF Q4 2024 Net Revenue of $8.5 million and launched the ZYNRELEF Vial Access Needle  in December 2024. U.S. District Court ruled in favor of Heron in patent lawsuit against Fresenius Kabi USA, LLC, and upheld the validity of CINVANTI patents which expire in 2035. CARY, N.C., Feb. 27, 2025 /PRNewswire/ -- Heron Therapeutics, Inc.  , a commercial-stage biotechnology company, today announced financial results for the three and twelve months ended December 31, 2024, and highlighted recent corporate updates.Partnership with Crosslink Network, LLC expands the promotional effort for ZYNRELEF within the orthopedic surgery marketplace for post-operative pain.Cash, cash equivalents, and short-term investments were $59.3 million as of December 31, 2024.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/heron-therapeutics-announces-fourth-quarter-124500761.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heron-therapeutics-announces-fourth-quarter-124500761.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4161","CINV","AC","RA","BK4135","HRTX","BK4563","MEC","BK4139"],"gpt_icon":0},{"id":"2514903870","title":"February 2025 Penny Stocks To Keep An Eye On","url":"https://stock-news.laohu8.com/highlight/detail?id=2514903870","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514903870?lang=en_us&edition=fundamental","pubTime":"2025-02-27 19:05","pubTimestamp":1740654319,"startTime":"0","endTime":"0","summary":"As February 2025 unfolds, the U.S. stock market has shown signs of resilience with the S&P 500 and Nasdaq Composite inching higher after a four-day losing streak, despite ongoing concerns about the economic outlook. In this context, penny stocks—often representing smaller or newer companies—continue to capture investor interest due to their affordability and potential for growth. While traditionally viewed with caution, these stocks can offer unique opportunities when backed by strong financials and solid fundamentals.Click here to see the full list of 732 stocks from our US Penny Stocks screener.Underneath we present a selection of stocks filtered out by our screen.Overview: ATRenew Inc. operates a platform for pre-owned consumer electronics transactions and services in China, with a market cap of approximately $623.33 million.Operations: The company's revenue is derived from its retail electronics segment, generat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/february-2025-penny-stocks-keep-110519303.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4122","BK4539","BK4213","VNDA","BK4179","BK4209","NRT","BK4076","SB","TTI","RERE","BK4563","PHX","BK4503","BK4021","PVL","BABB"],"gpt_icon":0},{"id":"2514687796","title":"So-Young to transfer listing to Nasdaq Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2514687796","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514687796?lang=en_us&edition=fundamental","pubTime":"2025-02-27 18:55","pubTimestamp":1740653726,"startTime":"0","endTime":"0","summary":"So-Young (SY) announced that Nasdaq approved the company’s request to transfer the listing of the company’s American depositary shares, with every ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/so-young-to-transfer-listing-to-nasdaq-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/so-young-to-transfer-listing-to-nasdaq-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKPKM429.USD","USJW.SI","TQQQ","NVIW.SI","USAW.SI","LU2210150020.SGD","MNQmain","BK4112","IE00B64PRP62.GBP","QLD","SY","LU2095319765.USD","BK4563","IE00BGHQF748.EUR","BK4503","BK4077","NQmain","BK4585","PSQ","TSYW.SI","IE00B3QW5Z07.USD","NDAQ","LU2210149790.SGD","SQQQ","BK4588","QID",".IXIC"],"gpt_icon":0},{"id":"2514746874","title":"so-Young Receives Approval to Transfer to Nasdaq Capital Market and Extension of Minimum Bid Price Compliance Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2514746874","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514746874?lang=en_us&edition=fundamental","pubTime":"2025-02-27 18:48","pubTimestamp":1740653283,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nTUA5PJWJ5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4077","BK4563","BK4503","SY"],"gpt_icon":0},{"id":"2514776758","title":"So-Young Receives Approval to Transfer to Nasdaq Capital Market and Extension of Minimum Bid Price Compliance Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2514776758","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514776758?lang=en_us&edition=fundamental","pubTime":"2025-02-27 18:47","pubTimestamp":1740653220,"startTime":"0","endTime":"0","summary":"BEIJING, Feb. 27, 2025 /PRNewswire/ -- So-Young International Inc.  , the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that on February 25, 2025, the Listing Qualifications department of the Nasdaq Stock Market LLC  approved the Company's request to transfer the listing of the Company's American depositary shares , with every 13 ADSs representing 10 Class A ordinary shares, from The Nasdaq Global Market to The Nasdaq Capital Market. The transfer is expected to take effect at the opening of business on February 27, 2025. The transfer of the Company's listing to the Nasdaq Capital Market is not expected to have any impact on trading in the Company's ADSs. The Company's ADSs will continue to trade uninterruptedly under the symbol \"SY.\" The Nasdaq Capital Market operates in substantially the same manner as the Nasdaq Global Market, and companies on the Nasdaq Capital Market must mee","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/young-receives-approval-transfer-nasdaq-104700629.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/young-receives-approval-transfer-nasdaq-104700629.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4077","LU2210150020.SGD","BK4503","NVIW.SI",".IXIC","LU2210149790.SGD","BK4563","BK4112","MNQmain","IE00B64PRP62.GBP","QID","BK4588","LU2095319765.USD","USJW.SI","QLD","TSYW.SI","NDAQ","IE00BGHQF748.EUR","SQQQ","IE00BKPKM429.USD","IE00B3QW5Z07.USD","NQmain","TQQQ","USAW.SI","SY","BK4585","PSQ"],"gpt_icon":1},{"id":"2514876780","title":"KANZHUN LIMITED to Report Fourth Quarter and FY2024 Results on March 11, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2514876780","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514876780?lang=en_us&edition=fundamental","pubTime":"2025-02-27 17:50","pubTimestamp":1740649800,"startTime":"0","endTime":"0","summary":"BEIJING, Feb.  27, 2025  (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced that it will rep","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/27/3033588/0/en/KANZHUN-LIMITED-to-Report-Fourth-Quarter-and-FY2024-Results-on-March-11-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4535","LU0359202008.SGD","LU2039709279.SGD","BK4077","IE00B29SXG58.USD","LU0359201612.USD","BK4509","BK4563","LU1023057109.AUD","LU1688375341.USD","BZ","BK4585","BK4539","BK4526","BK4505","BK4503","BK4588"],"gpt_icon":0},{"id":"2514497843","title":"Future of airport operations to take centre stage at inter airport Southeast Asia conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2514497843","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514497843?lang=en_us&edition=fundamental","pubTime":"2025-02-27 12:19","pubTimestamp":1740629940,"startTime":"0","endTime":"0","summary":"A spotlight on industry experts that will lead key conversations on making airports in Asia more sustainable.SINGAPORE, Feb. 27, 2025 /PRNewswire/ --Themed \"Airport Operations for Tomorrow\", inter airport Southeast Asia 2025  curated a lineup of conference sessions and the latest innovations to drive conversations on what a sustainable tomorrow looks like for Asia's airport operations and ground handling industry.From 25-27 March 2025, organised by RX, the 8th edition of IASEA is expected to gather over 4,000 attendees, 150 notable global brands and some 50 industry experts as speakers at the iconic Marina Bay Sands, Singapore.Shinichiro Motomiya, General Manager, Narita International Airport Corporation, shared, \"To ensure that airports can keep up with thissurging demand in air traffic today, it's become paramount for theindustry to accelerate conversations on what will make airportss","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/future-airport-operations-centre-stage-041900152.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/future-airport-operations-centre-stage-041900152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4551","BK4526","RLX","BK4123","CAAS","BK4075","RELX","BK4124","BK4563","ACV"],"gpt_icon":0},{"id":"2514289542","title":"Goldman Sachs Appoints McClure and Waldron to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2514289542","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514289542?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:59","pubTimestamp":1740607186,"startTime":"0","endTime":"0","summary":"An update from Goldman Sachs Group ( ($GS) ) is now available. On February 26, 2025, Goldman Sachs announced the appointment of KC McClure and John...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/goldman-sachs-appoints-mcclure-and-waldron-to-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/goldman-sachs-appoints-mcclure-and-waldron-to-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1868836757.USD","LU2237443978.SGD","LU0061475181.USD","BK4516","BK4526","LU2750360641.GBP","BK4533","IE00B19Z3B42.SGD","IE0034235188.USD","LU1868836591.USD","BK4608","LU0096364046.USD","LU2237443465.HKD","LU1868837300.USD","LU0106831901.USD","BK4588","BK4552","IE00BSNM7G36.USD","IE0004086264.USD","LU1668664300.SGD","IE00B19Z3581.USD","BK4550","LU2237443382.USD","IE0004091025.USD","LU1868836914.USD","BK4563","LU2471134796.USD","LU2471134523.USD","BK4504","LU2471134952.CNY","BK4127","IE0002270589.USD","BK4585","LU1868837136.USD","IE00BFXG1179.USD","LU2237443549.SGD","LU2237443622.USD","LU1791807156.HKD","GS","BK4607","LU2237443895.HKD","LU2237438978.USD","LU2750360997.AUD","BK4116","LU2471134879.HKD"],"gpt_icon":0},{"id":"2514231895","title":"Vista Energy Announces Shareholders’ Meeting with Key Financial Agenda","url":"https://stock-news.laohu8.com/highlight/detail?id=2514231895","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514231895?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:51","pubTimestamp":1740606692,"startTime":"0","endTime":"0","summary":"Vista Oil & Gas SAB de CV ( ($VIST) ) has issued an announcement. Vista Energy, S.A.B. de C.V. has announced its Annual Ordinary General Shareholde...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vista-energy-announces-shareholders-meeting-with-key-financial-agenda?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vista-energy-announces-shareholders-meeting-with-key-financial-agenda?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4213","BK4563","VIST","BK4585","BK4588"],"gpt_icon":0},{"id":"2514860846","title":"BRIEF-Relay Therapeutics Q4 Net Income USD -76.004 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2514860846","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514860846?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:05","pubTimestamp":1740603946,"startTime":"0","endTime":"0","summary":"BRIEF-Relay Therapeutics Q4 Net Income USD -76.004 Million\n\n\nFeb 26 (Reuters) - Relay Therapeutics Q4 operating expenses USD 84.979 million.\n\nQ4 operating income USD -84.979 million\nQ4 basic EPS USD -0.45","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nPLX375B03:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","RLAY","BK4139"],"gpt_icon":0},{"id":"2514867047","title":"Relay Therapeutics Q4 Basic EPS USD -0.45","url":"https://stock-news.laohu8.com/highlight/detail?id=2514867047","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514867047?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:05","pubTimestamp":1740603901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nPLX375B03:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RLAY","BK4139","BK4563"],"gpt_icon":0},{"id":"2514786088","title":"Relay Therapeutics Q4 Operating Expenses USD 84.979 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2514786088","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514786088?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:05","pubTimestamp":1740603901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nPLX375B03:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","BK4139","RLAY"],"gpt_icon":0},{"id":"2514898618","title":"Relay Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2514898618","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514898618?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:05","pubTimestamp":1740603900,"startTime":"0","endTime":"0","summary":"Initiation of Phase 3 ReDiscover-2 trial of RLY-2608 + fulvestrant anticipated in the middle of 2025 in PI3Kα-mutated, CDK4/6 pre-treated, HR+/HER2- metastatic breast cancer. Continued progression of other front-line breast cancer regimens, including initiation of atirmociclib triplet, and planning for development of future oral endocrine therapy combinations underway. Approximately $780 million in cash, cash equivalents and investments at end of Q4 2024, which will be prioritized to fully fund the execution of the ReDiscover-2 Phase 3 trial. CAMBRIDGE, Mass., Feb. 26, 2025  -- Relay Therapeutics, Inc. , a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today reported fourth quarter and full year 2024 financial results and corporate highlights.Relay Tx has conducted an end of Phase 2 meeting with the Food and Drug Administration  and announces the Phase 3 trial design, dose, and pla","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/relay-therapeutics-reports-fourth-quarter-210500946.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ORR","BK4139","PFS","RLAY","BK4563","BK4195","BK4211"],"gpt_icon":0},{"id":"2514089869","title":"REGENXBIO to Host Conference Call on March 13 to Discuss Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2514089869","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514089869?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:05","pubTimestamp":1740603900,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md., Feb. 26, 2025 /PRNewswire/ -- REGENXBIO Inc.  today announced that it will host a conference call on Thursday, March 13, at 4:30 p.m. ET to discuss its financial results for the fourth quarter and full year ended December 31, 2024, and recent operational highlights.Listeners can register for the webcast via this link. Analysts wishing to participate in the question and answer session should use this link. A replay of the webcast will be available via the company's investor website approximately two hours after the call's conclusion. Those who plan on participating are advised to join 15 minutes prior to the start time.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/regenxbio-host-conference-call-march-210500385.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/regenxbio-host-conference-call-march-210500385.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4218","BK4139","BK4181","HST","RGNX","BK4585","BK4563","BK4505","BK4588"],"gpt_icon":0},{"id":"2514867732","title":"Revolution Medicines Reports Fourth Quarter and Full Year 2024 Financial Results and Update on Corporate Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2514867732","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514867732?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:02","pubTimestamp":1740603720,"startTime":"0","endTime":"0","summary":"Company anticipates substantially completing enrollment this year in ongoing Phase 3 RASolute 302 trial of daraxonrasib in previously treated metastatic pancreatic cancer to enable expected data readout in 2026. Company is activating study sites for Phase 3 RASolve 301 trial of daraxonrasib in previously treated locally advanced or metastatic RAS mutant non-small cell lung cancer. Company anticipates initiating two additional registrational trials of daraxonrasib in earlier lines of treatment for pancreatic cancer in the second half of 2025. Revolution Medicines to hold webcast today at 4:30 p.m. Eastern Time. REDWOOD CITY, Calif., Feb. 26, 2025  -- Revolution Medicines, Inc. , a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced its financial results for the quarter and full year ended December 31, 2024, and provided an update on corporate progress.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/revolution-medicines-reports-fourth-quarter-210200565.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1720051108.HKD","LU1861214812.USD","LU1059921491.USD","LU2357305700.SGD","BK4585","BK4166","BK4503","LU0868494617.USD","CI","IE0002270589.USD","BK4139","LU1720051017.SGD","IE00B19Z3B42.SGD","LU1978683503.SGD","LU0348723411.USD","BK4605","LU0058720904.USD","RVMD","LU0289739699.SGD","PFS","LU1548497426.USD","LU1861220033.SGD","LU2298322129.HKD","PRGS","BK4195","LU1854103824.USD","BK4588","LU1861215975.USD","IE00B7SZLL34.SGD","BK4092","BK4563","LU0724618433.USD","BK4097","LU2065732104.USD","LU0124384867.USD","BK4512","LU2360107325.USD","RVMDW","IE00BZ199S13.USD","LU1854104046.USD","MDCO","QD","NE","LU1861219969.SGD","BK4196","ON","BK4211","IE00BD6J9T35.USD","OS","IE00B19Z3581.USD"],"gpt_icon":0}],"pageSize":16,"totalPage":20,"pageCount":13,"totalSize":305}]}}